Is It All About Age or Personalized Haploidentical Hematopoietic Stem Cell Transplantation for Elderly Patients?

Nelli Bejanyan

doi:10.1016/j.bbmt.2017.08.013

Is It All About Age or Personalized Haploidentical Hematopoietic Stem Cell Transplantation for Elderly Patients?

Nelli Bejanyan

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1602-1604
Number of pages	3
Journal	Biology of Blood and Marrow Transplantation
Volume	23
Issue number	10
DOIs	https://doi.org/10.1016/j.bbmt.2017.08.013
State	Published - Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AML
Elderly patients
Haploidentical transplant
MDS
Overall survival

Publisher link

10.1016/j.bbmt.2017.08.013

Find It

Find It at U of M Libraries

Cite this

@article{fa894de41266456d80af50a0c8440c48,

title = "Is It All About Age or Personalized Haploidentical Hematopoietic Stem Cell Transplantation for Elderly Patients?",

keywords = "AML, Elderly patients, Haploidentical transplant, MDS, Overall survival",

author = "Nelli Bejanyan",

year = "2017",

month = oct,

doi = "10.1016/j.bbmt.2017.08.013",

language = "English (US)",

volume = "23",

pages = "1602--1604",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",